Lilly: A Flowering of Diabetes Drugs

Lilly: A Flowering of Diabetes Drugs Q: Please update me on your latest diabetes drugs. A: Type II diabetes is caused by two drivers. One is insulin resistance. Actos, a drug we introduced in 1999 with Takeda Pharmaceutical, works on that. The other cause is beta-cell dysfunction. Byetta addresses this. What makes Byetta exciting is that it's what I would call a smart drug. It's in a new class of products called "incretin mimetics." It helps to reduce blood glucose and helps the body produce more insulin in the presence of high blood glucose. In other words, it works only when needed.

Contact: Michael Monheit, Esquire, Monheit Law, PC
Zyprexa: Lawyer: Side Effects: Diabetes